Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis

Invasive fungal infections (IFIs) are common among lung transplant recipients (LTRs). Posaconazole is an important antifungal agent for both prophylaxis and treatment of IFIs; however, detailed pharmacokinetic data are limited among LTRs, particularly those with cystic fibrosis (CF). Our objective w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Zhang, Hongfei, Nguyen, M. Hong, Clancy, Cornelius J., Joshi, Rujuta, Zhao, Wenchen, Ensor, Chris, Venkataramanan, Raman, Shields, Ryan K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2016
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879430/
https://ncbi.nlm.nih.gov/pubmed/27021324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00424-16
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia